prof. dr. Anja Geerts
- ORCID iD
-
0000-0002-2218-9081
Show
Sort by
-
Reply : can pFIB scores reliably exclude significant liver fibrosis in pediatric MASLD?
-
Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD
-
A larger decline of IgG after initiation of treatment in patients with AIH is associated with complete biochemical response despite having normal baseline IgG levels
-
Harnessing human immune system mouse models to validate NADPH oxidase 1 inhibition as a treatment for hepatocellular carcinoma
-
Therapeutic plasma exchange improves outcomes in Amanita phalloides induced acute liver failure-results from an interim analysis of the Amanita-PEX study
-
- Journal Article
- A1
- open access
The double-edged sword of metabolic and bariatric surgery : extending the biliary limb can trigger bacterial translocation, sepsis, and liver inflammation : an experimental study
-
- Journal Article
- A2
- open access
Early plasmapheresis in type 2 benign recurrent intrahepatic cholestasis : a case report and review of literature
-
Reassessing the prevalence of portopulmonary hypertension : insights from a prospective study in cirrhotic patients
-
The burden of ascites in cirrhosis
-
- Journal Article
- A1
- open access
Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD